Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

                    Notice is hereby given that, on May 14, 2018, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. § 4301                     *et seq.*                     (“the Act”), Medical CBRN Defense Consortium (“MCDC”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Spero Therapeutics, Inc., Cambridge, MA; DCN Diagnostics, Carlsbad, CA; Silver Lake Research                           ( print page 28447)                        Corporation, Azusa, CA; Coagulant Therapeutics, Mill Valley, CA; Duke University, Durham, NC; International AIDS Vaccine Initiative (IAVI), New York, NY; AN2 Therapeutics, Inc., Menlo Park, CA; University of Nevada Reno, Reno, NV; New Mexico Institute of Mining and Technology, Socorro, NM; VecTOR Test Systems, Inc., Thousand Oaks, CA; The Regents of the University of California, Irvine, Irvine, CA; The Wistar Institute, Philadelphia, PA; Chenega Support Services, LLC, San Antonia, TX; PlantVax Inc., Rockville, MD; Binergy Scientific, Inc., Atlanta, GA; Zeteo Tech, Inc., Sykesville, MD; The Regents of University of New Mexico, Health Sciences Center, Albuquerque, NM; Rubicon Biotechnology, Lake Forest, CA; Innovative Emergency Management, Inc. (IEM), Arlington, VA; Macromoltek, Austin, TX; Paratek Pharmaceuticals, Boston, MA; Terminal Horizon Operations and Resourcing, Inc. (THOR), St. Petersburg, FL; Phosphorex Inc., Hopkinton, MA; Celina Tent, Inc., Celina, OH; Medinstill Development LLC, New Milford, CT; BioHybrid Solutions LLC, Pittsburgh, PA; GeneCapture Inc., Huntsville, AL; University of Arizona (Arizona Board of Regents), Tucson, AZ; Peregrine Technical Solutions, LLC, Yorktown, VA; and DxDiscovery, Inc., Reno, NV, have been added as parties to this venture.                

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership.

                    On November 13, 2015, MCDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the                     **Federal Register**                     pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513).                

                    The last notification was filed with the Department on January 16, 2018. A notice was published in the                     **Federal Register**                     pursuant to Section 6(b) of the Act on February 27, 2018 (83 FR 8506).                

Patricia A. Brink,

Director of Civil Enforcement, Antitrust Division.

[FR Doc. 2018-13061 Filed 6-18-18; 8:45 am]

 BILLING CODE 4410-11-P